News

With this positive opinion, CHMP has recommended the European Commission to grant the European Marketing Authorisation (MA). The product will be marketed in the EU under the name

MSD and Adcock Ingram intend to co-promote and distribute products from various therapeutic areas including: asthma, dermatology, hypercholesterolemia, hypertension, migraine and osteoporosis as well as a portfolio of

Wolters Kluwer Health said that its ProVation MD software for procedure documentation and coding compliance replaces dictation/transcription and streamlines the coding and billing process. Wolters Kluwer Health claimed

SOCMA’s new members include: Arichem, Huffmaster, Marsh USA, NCM Hersbit Chemical and NCM Hersbit Chemical. The companies, who range from specialty chemical manufacturers to security providers to insurance

The approval of Dulera is based, in part, on Phase III studies that evaluated the safety and efficacy in patients 12 years of age and older with persistent

miRagen is planning to develop and commercialise single-stranded LNA-based product candidates intended for the treatment of cardiovascular disease by utilizing Santaris Pharma proprietary Locked Nucleic Acid (LNA) Drug

The worldwide suspension of the program, which is effective immediately, follows a small number of reports of Pfizer Tanezumab patients experiencing the worsening of osteoarthritis leading to joint

According to BioSurplus, for the past 15 years, Ms Scott served as a partner with RA Capital Advisors, a private investment bank, where she completed financial transactions totaling

According to Frost & Sullivan analysis most pharmaceutical companies consider emerging markets lucrative due to their economical infrastructure and manpower costs and a significant untapped market potential with